Paradeep parivahan Limited has announced the appointment of Mr. Suryasnata Rath as Chief Financial Officer and Key Managerial Personnel, effective March 20, 2026. The decision was made during a board meeting held on the same date, following a recommendation from the company's Nomination and Remuneration Committee.

Board Meeting and Regulatory Disclosure

The board of directors convened on March 20, 2026, to consider and approve the CFO appointment. The meeting commenced at 4:00 p.m. and concluded at 4:40 p.m., with the appointment being the primary agenda item discussed. The company has formally notified BSE Limited under scrip code 544383, ensuring compliance with regulatory requirements.

New CFO Profile and Experience

Mr. Suryasnata Rath has been associated with Paradeep Parivahan Limited as Manager – Finance & Accounts prior to his elevation to the CFO position. With a strong background in accounting, finance, and regulatory compliance, he has played a key role in managing the company's financial operations, including financial reporting, taxation, budgeting, and internal controls.

Key Responsibilities and Expertise

In his new role as Chief Financial Officer, Mr. Rath will be responsible for overseeing the overall financial strategy, financial planning and analysis, regulatory compliance, and stakeholder reporting. His appointment recognizes his performance, experience, and in-depth understanding of the company's financial systems.

Mr. Rath possesses 12 years of experience in the field of finance and accounts and has demonstrated expertise in handling corporate financial matters in compliance with applicable laws and regulations. He brings strong analytical skills, financial discipline, and compliance-oriented approach to the organization.

Regulatory Compliance Framework

The appointment has been made in accordance with Section 203 of the Companies Act, 2013, and Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided all required details as per SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and SEBI Circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.

The appointment represents an internal promotion, recognizing Mr. Rath's contributions to the company's financial operations and his readiness to take on expanded responsibilities as a Key Managerial Personnel. The formal disclosure was signed by Managing Director Khalid Khan (DIN-06432054), ensuring proper corporate governance protocols.

Paradeep Parivahan Limited has secured a significant regulatory milestone with BSE Limited granting in-principle approval for its preferential issue of convertible warrants. The approval, dated March 09, 2026, represents a key step in the company's capital raising initiative.

Warrant Issue Details

The BSE approval covers the issuance of 10,40,000 fully convertible equity warrants through preferential allotment on a private placement basis. The warrants are priced strategically to attract both promoter and non-promoter investors.

Regulatory Framework and Compliance

The approval falls under Regulation 28(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. BSE Limited issued the approval through letter reference number LOD/PREF/MV/FIP/1834/2025-26, ensuring compliance with established regulatory frameworks.

The company must adhere to multiple regulatory requirements including:

• Companies Act, 2013
• Securities Contracts (Regulation) Act, 1956
• SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
• SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Timeline and Operational Requirements

The in-principle approval carries specific time-bound obligations for Paradeep Parivahan Limited. The approval remains valid for 15 days from the approval date, creating urgency for the company to proceed with the allotment process.

Internal Controls and Investor Safeguards

BSE has mandated specific internal control measures to prevent regulatory violations. The company must obtain undertakings from allottees confirming they will not engage in intra-day trading or sell company shares until the allotment date. This requirement aims to ensure compliance with SEBI ICDR Regulations and maintain market integrity.

Strategic Impact and Next Steps

The approval enables Paradeep Parivahan Limited to proceed with warrant issuance and allotment as per board, shareholder, and stock exchange approvals. The company must now focus on completing the allotment process within the specified timeframe and ensuring full regulatory compliance throughout the process.